State # with Serious Mental Illness in Marketplaces # with Substance ...

0 downloads 146 Views 61KB Size Report
Buprenorphine Use and Payment Types, September, 2016 and CDC Mortality Data. Tabulations; Mortality rates are age adjust
State

Alaska Arizona Maine Nevada Ohio Pennsylvania Tennessee West Virginia

# with Serious Mental Illness in Marketplaces

# with Substance Use Disorder in Marketplaces

Total All Mental Illness and Substance Use Disorders in Marketplace

1,296 7,177 1,277 6,432 13,955 12,853 8,124 3,207

2,754 21,553 8,306 12,864 29,656 51,415 30,466 2,916

5,136 63,344 19,232 22,299 69,255 99,616 78,807 9,682

# with Mental Illness and Substance Use Disorder conditions in Medicaid Expansion 5,389 15,400 NA 28,080 151,257 80,910 NA 204,819

Total BH (Columns 4 + 5)

10,525 78,744 19,232 50,379 220,512 180,526 78,807 214,501

Table 1: People with Behavioral Health Needs in Exchanges and Expansion Population 2016 State Alaska Arizona Maine Nevada Ohio Pennsylvania Tennessee West Virginia U.S.

Drug Overdose Deaths (rate/100,000) 122 (16.0) 1,274 (19.0) 269 (21.2) 619 (20.4) 3,310 (29.9) 3,264 (26.3) 1,457 (22.2) 725 (41.5) 52,404 (16.3)

Rx Opioid Use per 1000 population 566 693 705 816 828 795 1,161 1,049 695

Buprenorphine use per 1000 population 30 19 114 24 69 75 118 158 39

% Share of Bupe paid by Medicaid 34.2% 14.9 37.8 11.9 49.5 29.2 10.0 44.7 24.2

Table 2: Opioid related Mortality, Prescription Opioid Use and Buprenorphine based MAT 2015

Source: IMSHealth, Use of Opioid Recovery Medications Recent Evidence on State Level

Buprenorphine Use and Payment Types, September, 2016 and CDC Mortality Data Tabulations; Mortality rates are age adjusted

Health Insurance Marketplaces Medicaid Expansion

Behavioral Health Care Service Users 554,488 1,286,550

Dollars

$981 million $4.5 billion

Table 3: U.S. Reductions in covered users of behavioral health care and spending covered by insurance programs